Netherlands Pharmaceuticals & Healthcare Report Q2 2013
Published by Business Monitor International
on Mar 6, 2013
, 87 pages
PDF - Download Now with 3 Quarterly Updates format - Delivered by download
BMI View: While the recentlyproposedhealthcare cost-containment measures inthe Netherlandsdo not include price cuts on medicines, we believe measures such as increasedhealth insurance premiumswillact asmarket access barriers, creating a business environment that ultimately restrictshealthcarecompanies' revenue-earning opportunities. Furthermore, increasedout-of-pocketpayments will not go down well with patients, particularly asthe Dutchare avid consumers of free high-quality healthcare.